Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barr

Showing results (761-770 of 1,036) with videos related to

Pageof 104
Sort By:
Haematologica|November 25, 2017
Survival adjusting for crossover: phase 3 study of ibrutinib <i>vs</i>. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphomaSteven Coutre, Alessandra Tedeschi, Tadeusz Robak, et al.
British Journal of Haematology|December 18, 2019
Efficacy of lenalidomide in high-risk diffuse large B-cell lymphomaThomas D Rodgers, Andrea Baran, Patrick M Reagan, et al.
Open Biology|November 6, 2024
SID-2 is a conserved extracellular vesicle protein that is not associated with environmental RNAi in parasitic nematodesFrances Blow, Kate Jeffrey, Franklin Wang-Ngai Chow, et al.
Leukemia & Lymphoma|July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretationKah Poh Loh, Andrea Baran, Christina Y Lee, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatientsRic M Procyshyn, William G Honer, Tony K Y Wu, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 16, 2013
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosisTodd S Woodward, Kwanghee Jung, Geoffrey N Smith, et al.
Cancers|January 21, 2023
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 StudyJennifer A Woyach, Paul M Barr, Thomas J Kipps, et al.
Acta Neuropathologica|November 21, 2016
Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's diseaseAlfredo Ramos-Miguel, Ken Sawada, Andrea A Jones, et al.
Nanoscale|November 13, 2018
New nanoscale toughening mechanisms mitigate embrittlement in binary nanocrystalline alloysNathan M Heckman, Stephen M Foiles, Christopher J O'Brien, et al.
CNS Drugs|August 20, 2018
Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic ReviewDavid D Kim, Alasdair M Barr, Yunsun Chung, et al.
Pageof 104

Showing results (761-770 of 1,036) with videos related to

Sort By:
Pageof 104
Haematologica|November 25, 2017
Survival adjusting for crossover: phase 3 study of ibrutinib <i>vs</i>. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphomaSteven Coutre, Alessandra Tedeschi, Tadeusz Robak, et al.
British Journal of Haematology|December 18, 2019
Efficacy of lenalidomide in high-risk diffuse large B-cell lymphomaThomas D Rodgers, Andrea Baran, Patrick M Reagan, et al.
Open Biology|November 6, 2024
SID-2 is a conserved extracellular vesicle protein that is not associated with environmental RNAi in parasitic nematodesFrances Blow, Kate Jeffrey, Franklin Wang-Ngai Chow, et al.
Leukemia & Lymphoma|July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretationKah Poh Loh, Andrea Baran, Christina Y Lee, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatientsRic M Procyshyn, William G Honer, Tony K Y Wu, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 16, 2013
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosisTodd S Woodward, Kwanghee Jung, Geoffrey N Smith, et al.
Cancers|January 21, 2023
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 StudyJennifer A Woyach, Paul M Barr, Thomas J Kipps, et al.
Acta Neuropathologica|November 21, 2016
Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's diseaseAlfredo Ramos-Miguel, Ken Sawada, Andrea A Jones, et al.
Nanoscale|November 13, 2018
New nanoscale toughening mechanisms mitigate embrittlement in binary nanocrystalline alloysNathan M Heckman, Stephen M Foiles, Christopher J O'Brien, et al.
CNS Drugs|August 20, 2018
Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic ReviewDavid D Kim, Alasdair M Barr, Yunsun Chung, et al.
Pageof 104